| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | IC50 | 4.5 [1] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | Ki | 0.3 [1] |
| Bctc | IC50 | 9.6 [1] |
| Bctc | Ki | 4.32 [1], 10.5 [2] |
| (2S)-2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | IC50 | 0.8 [1], 6.3 [2] |
| (2S)-2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | Ki | 0.2 [1] |
| Capsazepine | IC50 | 74.0 [1] |
| Capsazepine | Ki | 120.0 [1] |
| Amg-517 | IC50 | 0.76 [1] |
| 1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea | IC50 | 3.0 [1], 4.0 [2] |
| 1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea | Ki | 5.0 [1], 18.3 [2] |
| (2S)-N-[(4-Tert-butylphenyl)methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 174.0 [1], 1210.0 [2], 1281.0 [3] |
| (2S)-N-[(4-Tert-butylphenyl)methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 6.6 [1], 20.0 [2], 28.0 [3] |
| Resiniferatoxin | Ki | 0.48 [1], 1.23 [2], 14.0 [3], 23.1 [4] |
| Iodoresiniferatoxin | IC50 | 4000.0 [1] |
| Iodoresiniferatoxin | Ki | 5.87 [1], 5.9 [2], 11.8 [3] |
| (R)-1-(5-Tert-Butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea | IC50 | 0.7 [1], 3.0 [2], 4.0 [3] |
| N-(4-(Trifluoromethyl)phenyl)-4-(3-(trifluoromethyl)pyridin-2-yl)benzamide | IC50 | 3.0 [1], 13.0 [2], 14.0 [3] |
| N-[(4-Tert-butylphenyl)methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 1990.0 [1] |
| N-[(4-Tert-butylphenyl)methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 5.1 [1], 12.7 [2], 44.5 [3], 89.0 [4] |
| (R)-8-{5-[3-Methyl-4-(trifluoromethyl)phenyl]oxazol-2-ylamino}-1,2,3,4-tetrahydronaphthalen-2-ol | IC50 | 12.0 [1], 15.0 [2], 180.0 [3], 100000.0 [4] |
| N-[[2-Cyclohexyl-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 14.1 [1], 43.4 [2] |
| N-[[2-Cyclohexyl-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.2 [1], 0.6 [2] |
| 1-[3-Fluoro-4-(methanesulfonamidomethyl)phenyl]-3-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]urea | Ki | 5.0 [1], 6.77 [2], 11.5 [3], 12.5 [4] |
| (2S)-N-[[2-Cyclohexylsulfanyl-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 22.3 [1], 1000.0 [2] |
| (2S)-N-[[2-Cyclohexylsulfanyl-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.05 [1], 0.4 [2] |
| (2S)-N-[[2-(3-Chlorophenyl)-5-(trifluoromethyl)pyrazol-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 8.0 [1], 8.1 [2] |
| (2S)-N-[[2-(3-Chlorophenyl)-5-(trifluoromethyl)pyrazol-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.1 [1] |
| Capsaicin | IC50 | 8.0 [1] |
| Capsaicin | Ki | 6.0 [1], 1140.0 [2], 2530.0 [3] |
| (E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide | IC50 | 25.0 [1], 93.0 [2], 1200.0 [3], 3200.0 [4] |
| Ppahv | Ki | 0.12 [1], 0.45 [2], 2100.0 [3], 6400.0 [4] |
| Pinosylvin methyl ether | IC50 | 10000.0 [1], 15000.0 [2], 23700.0 [3], 30000.0 [4] |
| N-[4-(Trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)pyridin-2-yl]quinazolin-4-amine | IC50 | 0.8 [1], 1.1 [2] |
| 3-(2-Morpholino-6-(trifluoromethyl)pyridin-3-yl)-N-(quinolin-7-yl)acrylamide | IC50 | 1.3 [1], 1.9 [2], 116.0 [3] |
| 3-(2-Morpholino-6-(trifluoromethyl)pyridin-3-yl)-N-(quinolin-7-yl)acrylamide | Ki | 1.2 [1] |
| (2R)-4-(6-Chloro-4-methylpyridazin-3-yl)-N-(6-fluoro-1,3-benzothiazol-2-yl)-2-methylpiperazine-1-carboxamide | IC50 | 103.0 [1], 103.3 [2], 226.0 [3], 226.3 [4] |
| (R)-6-Tert-butyl-2-(4-(3-chloropyridin-2-yl)-2-methylpiperazin-1-yl)-1H-benzo[d]imidazole | IC50 | 90.0 [1], 90.4 [2], 104.0 [3] |
| (R)-6-Tert-butyl-2-(2-methyl-4-(3-methylpyridin-2-yl)piperazin-1-yl)-1H-benzo[d]imidazole | IC50 | 70.0 [1], 70.4 [2], 597.0 [3] |
| (R)-6-Tert-butyl-2-(2-methyl-4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1H-benzo[d]imidazole | IC50 | 32.0 [1], 32.4 [2], 1778.0 [3] |
| N-[4-(Trifluoromethyl)phenyl]-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine-1-carboxamide | IC50 | 3.0 [1], 4.0 [2], 57.0 [3] |
| N-[4-(Trifluoromethyl)phenyl]-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine-1-carboxamide | Ki | 38.0 [1] |
| N-[[2-Cyclopentylsulfanyl-4-(trifluoromethyl)phenyl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 32.0 [1], 37.2 [2] |
| N-[[2-Cyclopentylsulfanyl-4-(trifluoromethyl)phenyl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.03 [1], 0.3 [2] |
| 2-(4-Amino-3,5-dichlorophenyl)-N-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]acetamide | IC50 | 12.8 [1], 158.0 [2] |
| 2-(4-Amino-3,5-dichlorophenyl)-N-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]acetamide | Ki | 0.1 [1], 0.3 [2] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-(2-methylpropoxy)-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | IC50 | 52.6 [1], 67.5 [2] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-(2-methylpropoxy)-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | Ki | 0.29 [1], 0.5 [2] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-(4-fluorophenyl)-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | Ki | 0.4 [1], 0.84 [2], 25.9 [3], 130.8 [4] |
| N-[[2-Butoxy-6-[chloro(difluoro)methyl]pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 7.0 [1], 8.3 [2] |
| N-[[2-Butoxy-6-[chloro(difluoro)methyl]pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.02 [1], 0.3 [2] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-2-(3-methylphenyl)-N-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]acetamide | IC50 | 36.2 [1], 86.7 [2] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-2-(3-methylphenyl)-N-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]acetamide | Ki | 0.1 [1], 0.25 [2] |
| (1S)-N-(4-Tert-butylcyclohexyl)-3-oxo-1,2-diphenyl-2,7-diazaspiro[3.5]nonane-7-carboxamide | IC50 | 32.0 [1], 49.0 [2], 232.0 [3], 528.0 [4] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-phenylmethoxy-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | IC50 | 18.6 [1], 52.3 [2] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-phenylmethoxy-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | Ki | 0.0 [1], 0.5 [2] |
| N-[[6-[Chloro(difluoro)methyl]-2-cyclopentyloxypyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 18.5 [1], 19.3 [2] |
| N-[[6-[Chloro(difluoro)methyl]-2-cyclopentyloxypyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.04 [1], 0.5 [2] |
| (2S)-N-[[2-Cyclohexylsulfanyl-4-(trifluoromethyl)phenyl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 7.3 [1], 20.4 [2] |
| (2S)-N-[[2-Cyclohexylsulfanyl-4-(trifluoromethyl)phenyl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.03 [1], 0.3 [2] |
| 4-(3-Chloropyridin-2-yl)-4-fluoro-N-(6-fluoro-1,3-benzothiazol-2-yl)piperidine-1-carboxamide | IC50 | 508.0 [1], 1463.0 [2] |
| Jnj-17203212 | IC50 | 16.0 [1], 65.0 [2], 160.0 [3] |
| 1-[3-(Trifluoromethyl)pyridin-2-yl]-N-[4-(trifluoromethylsulfonyl)phenyl]-3,6-dihydro-2H-pyridine-4-carboxamide | IC50 | 24.0 [1], 14000.0 [2], 20200.0 [3] |
| 1-Isoquinolin-5-yl-3-{1-[4-(trifluoromethyl)phenyl]ethyl}urea | IC50 | 22.0 [1] |
| (E)-3-[2-Piperidin-1-yl-6-(trifluoromethyl)pyridin-3-yl]-N-quinolin-7-ylprop-2-enamide | IC50 | 0.42 [1], 1.0 [2] |
| (E)-3-[2-Piperidin-1-yl-6-(trifluoromethyl)pyridin-3-yl]-N-quinolin-7-ylprop-2-enamide | Ki | 4.4 [1] |
| N-[[2-Cyclohexylsulfanyl-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.9 [1] |
| 3-1H-Indazol-4-yl-1-{1-[4-(trifluoromethyl)phenyl]ethyl}urea | IC50 | 47.0 [1] |
| 3-(7-Hydroxynaphthalen-1-yl)-1-[3-(methylsulfanyl)phenyl]urea | IC50 | 3.9 [1], 13.0 [2], 22.0 [3] |
| 6-(4-Fluorophenyl)-2-methyl-N-(2-methylbenzothiazol-5-yl)nicotinamide | IC50 | 9.0 [1], 39.81 [2], 49.0 [3] |
| 3-Amino-5-({6-[4-(trifluoromethyl)phenyl]pyrimidin-4-yl}oxy)-1,2-dihydroquinoxalin-2-one | IC50 | 0.4 [1], 0.8 [2], 0.9 [3] |
| Urea, N-5-isoquinolinyl-N'-[[3-(trifluoromethyl)phenyl]methyl]- | IC50 | 11.0 [1], 51.0 [2] |
| Urea, N-5-isoquinolinyl-N'-[[3-(trifluoromethyl)phenyl]methyl]- | Ki | 23.0 [1] |
| N-[[2-(Dipropylamino)-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 14.7 [1] |
| N-[[2-(Dipropylamino)-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.2 [1] |
| N-[[2-(4-Benzylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 40.0 [1] |
| N-[[2-(4-Benzylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.2 [1] |
| 2-Morpholin-4-yl-N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)pyridin-2-yl]-5,6,8,9-tetrahydropyrimido[4,5-d]azepin-4-amine | IC50 | 5.3 [1], 6.0 [2] |
| N-[[2-Cyclopentyloxy-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 28.7 [1] |
| N-[[2-Cyclopentyloxy-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.9 [1] |
| 2-Piperazin-1-yl-N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)pyridin-2-yl]-5,6,8,9-tetrahydropyrimido[4,5-d]azepin-4-amine | IC50 | 3300.0 [1], 3350.0 [2] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-[(4-fluorophenyl)methoxy]-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | IC50 | 25.0 [1] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-[(4-fluorophenyl)methoxy]-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | Ki | 2.5 [1] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[6-(trifluoromethyl)-2-[4-(trifluoromethyl)piperidin-1-yl]pyridin-3-yl]methyl]propanamide | IC50 | 31.0 [1] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[6-(trifluoromethyl)-2-[4-(trifluoromethyl)piperidin-1-yl]pyridin-3-yl]methyl]propanamide | Ki | 0.4 [1], 0.6 [2] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-(3-methylbutoxy)-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | IC50 | 15.1 [1] |
| 2-[3-Fluoro-4-(methanesulfonamido)phenyl]-N-[[2-(3-methylbutoxy)-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | Ki | 0.8 [1] |
| N-[[2-[(2-Chlorophenyl)methylsulfanyl]-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | IC50 | 620.0 [1] |
| N-[[2-[(2-Chlorophenyl)methylsulfanyl]-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 4.9 [1] |
| 1-(4-Tert-Butyl-benzyl)-3-isoquinolin-5-yl-urea | IC50 | 3.0 [1] |
| 1-(4-Tert-Butyl-benzyl)-3-isoquinolin-5-yl-urea | Ki | 0.3 [1], 13.8 [2] |
| Urea, N-5-isoquinolinyl-N'-[2-[3-(trifluoromethyl)phenyl]ethyl]- | IC50 | 19.0 [1], 20.0 [2] |
| Urea, N-5-isoquinolinyl-N'-[2-[3-(trifluoromethyl)phenyl]ethyl]- | Ki | 41.0 [1] |
| Urea, N-5-isoquinolinyl-N'-[2-[4-(trifluoromethyl)phenyl]ethyl]- | IC50 | 19.0 [1] |
| Urea, N-5-isoquinolinyl-N'-[2-[4-(trifluoromethyl)phenyl]ethyl]- | Ki | 22.0 [1] |
| N-(4-Nitrophenyl)-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine-1-carboxamide | IC50 | 3.0 [1], 74.0 [2] |
| 4-[2-(Trifluoromethyl)phenyl]-N-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carboxamide | IC50 | 3.0 [1], 5.0 [2], 65.0 [3] |
| N-[[2-(4-Tert-butylcyclohexyl)-6-(trifluoromethyl)pyridin-3-yl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide | Ki | 0.3 [1], 1.3 [2] |
| 1-[3-Fluoro-4-(methanesulfonamido)phenyl]-1-(3-methylphenyl)-3-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]urea | Ki | 490.0 [1], 860.0 [2], 2200.0 [3] |
| 2-[3,5-Difluoro-4-(methanesulfonamido)phenyl]-N-[[2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl]methyl]propanamide | IC50 | 8.1 [1], 8.7 [2] |